Evidence map›Paper›PMID 29507712›Full record

ArticleClinical sarcoma research2018

Different quality of treatment in retroperitoneal sarcomas (RPS) according to hospital-case volume and surgeon-case volume: a retrospective regional analysis in Italy.

Sergio Sandrucci, Agostino Ponzetti, Claudio Gianotti, Baudolino Mussa, Patrizia Lista, Giovanni Grignani, Marinella Mistrangelo, Oscar Bertetto, Daniela Di Cuonzo, Giovannino Ciccone

Abstract read
In one paragraph

Article in Clinical sarcoma research, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Retroperitoneal Sarcomas: a Current Review on Management.Indian journal of surgical oncology · 2022
    Review
  6. Article
  7. Article
  8. Article
  9. T4 retroperitoneal liposarcoma. Challenges of big size sarcomas surgical treatment.Romanian journal of morphology and embryology = Revue roumaine de morphologie et embryologie
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Sergio Sandrucci1Visceral Sarcoma Unit, University of Turin, Cso Dogliotti 14, 10126 Turin, Italy.ORCID 0000-0003-3671-2117
Agostino PonzettiMedical Oncology 1 Division, Città della Salute e della Scienza, Turin, Italy.
Claudio Gianotti1Visceral Sarcoma Unit, University of Turin, Cso Dogliotti 14, 10126 Turin, Italy.
Baudolino Mussa3Department of Surgical Sciences, University of Turin, Turin, Italy.
Patrizia ListaMedical Oncology 1 Division, Città della Salute e della Scienza, Turin, Italy.
Giovanni Grignani4Department of Medical Oncology, Candiolo Cancer Institute-FPO, IRCCS, Candiolo, Italy.
Marinella MistrangeloMedical Oncology 1 Division, Città della Salute e della Scienza, Turin, Italy.
Oscar BertettoRegional Oncologic Network Department, Turin, Italy.
Daniela Di CuonzoCancer Epidemiology Unit, Città della Salute e della Scienza, Turin, Italy.
Giovannino CicconeCancer Epidemiology Unit, Città della Salute e della Scienza, Turin, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundRetroperitoneal sarcomas (RPS) should be surgically managed in specialized sarcoma centers. However, it is not clearly demonstrated if clinical outcome is more influenced by Center Case Volume (CCV) or by Surgeon Case Volume (SCV). The aim of this study is to retrospectively explore the relationship between CCV and SCV and the quality of surgery in a wide region of Northern Italy.

methodsWe retrospectively collected data about patients M0 surgically treated for RPSs in 22 different hospitals from 2006 to 2011, dividing them in two hospital groups according to sarcoma clinical activity volume (HCV, high case volume or LCV, low case volume hospitals). The HCV group (> 100 sarcomas observed per year) included a Comprehensive Cancer Center (HVCCC) with a high sarcoma SCV (> 20 cases/year), and a Tertiary Academic Hospital (HVTCA) with multiple surgeon teams and a low sarcoma SCV (≤ 5 cases/year for each involved surgeon). All other hospitals were included in the LCV group (< 100 sarcomas observed per year).

resultsData regarding 138 patients were collected. Patients coming from LCV hospitals (66) were excluded from the analysis as prognostic data were frequently not available. Among the 72 remaining cases of HCV hospitals 60% of cases had R0/R1 margins, with a more favorable distribution of R0/R1 versus R2 in HVCCC compared to HVTCA.

conclusionsIn HCV hospitals, sarcoma SCV may significantly influence RPS treatment quality. In low-volume centers surgical reports can often miss important prognostic issues and surgical quality is generally poor.

Indexed as

Hospital case volumeMultidisciplinary managementQuality of surgeryRetroperitoneal sarcomasRetrospective analysisSurgeon case volume

Identifiers

PMID29507712
PMCPMC5830336

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.